Surrogate markers of atherosclerosis: impact of statins (Q35114365)

6 August 2017

1 reference

title

Surrogate markers of atherosclerosis: impact of statins (English)

1 reference

6 August 2017

1 reference

2

Albert Wiegman

1 reference

6 August 2017

1

John J P Kastelein

1 reference

6 August 2017

Eric de Groot

3

1 reference

6 August 2017

publication date

1 March 2003

1 reference

Atherosclerosis. Supplements

6 August 2017

published in

1 reference

6 August 2017

volume

4

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

31-36

1 reference

The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900007-2

7 January 2021

Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900007-2

7 January 2021

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900007-2

7 January 2021

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900007-2

7 January 2021

Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900007-2

7 January 2021

B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900007-2

7 January 2021

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900007-2

7 January 2021

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900007-2

7 January 2021

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900007-2

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900007-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900007-2

7 January 2021

Carotid intima-media thickness in young patients with familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900007-2

7 January 2021

10.1016/S1567-5688(03)00007-2

Identifiers

DOI

1 reference

6 August 2017

1 reference